Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Recruiting 49Active not recruiting 19Completed 18Terminated 16Withdrawn 9Not yet recruiting 7Unknown 5Enrolling by invitation 1

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Breast 3Thoracic 1Other solid neoplasm 1Head & Neck 1

Conditions

Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 1Neoplasms 1Mesothelioma, Malignant 1Head and Neck Neoplasms 1Breast Diseases 1

Interventions

Cisplatin 352Oxaliplatin 262Capecitabine 258Radiotherapy 240Gemcitabine 223Docetaxel 223Carboplatin 223Cyclophosphamide 219Drug Therapy 218Paclitaxel 205apatinib 201Bevacizumab 195camrelizumab 190Fluorouracil 187sintilimab 133Blood Specimen Collection 125Irinotecan 124Dexamethasone 123Etoposide 119Radiosurgery 118toripalimab 117Surgical Procedures, Operative 115pembrolizumab 110Pemetrexed 108anlotinib 105S 1 (combination) 105Surveys and Questionnaires 101Leucovorin 101Nivolumab 98tislelizumab 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Unknown × OTHER × abemaciclib × Clear all
NCT06341283 2024-05-10

A Retrospective Real-world Study of Abemaciclib in HR+ Breast Cancer

The Affiliated Hospital of Qingdao University

Unknown
200 enrolled
Breast

Breast Diseases, Breast Neoplasms, Neoplasms

NCT05464173 2024-01-22

CINDERELLA

Fudan University

Phase 1/2 Unknown
44 enrolled
Breast

Breast Neoplasms

NCT03654833 2023-03-14

MiST

University of Leicester

Phase 2 Unknown
186 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT04852081 2021-04-21

Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study.

Blokhin's Russian Cancer Research Center

Unknown
1,000 enrolled
Breast

Breast Neoplasms

NCT03356587 2017-11-29

A Biomarker-driven, Open Label, Single Arm, Multicentre Phase II Study of Abemaciclib in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Who Failed to Platinum-based Therapy

Seoul National University Hospital

Phase 2 Unknown
32 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡